The science of regenerative aesthetics
KYLYS AESTHETICS develops a new generation of medical devices for aesthetics, based on Hyaluronic Acid and derived from a patented technology of the University of Geneva, designed to deliver safer, more natural, and longer-lasting results.
Supported by leading institutions and partners
Our solution
A patented regenerative approach
Our hyaluronic acid formulation is unique: it does not just fill, it regenerates. This is a major breakthrough for the safety and efficacy of aesthetic treatments
Unique market advantages:
Regenerative properties
Stimulates tissue regeneration for natural, authentic effects without the "overfilled" look.
Enhanced comfort & safety
Our formulations are optimized for each application to enhance performance and minimize patient discomfort.
Rigorous scientific validation
Backed by years of academic research and scientific data.
The market challenge
The limitations of current dermal fillers
The “dermal filler” market is booming, but existing solutions have major drawbacks that hamper their potential and patient satisfaction.
unnatural results
Often artificial-looking results and product migration that can alter facial harmony.
Side effects & pain
Injections can be painful, causing bruising and inflammation.
Purely mechanical action
Conventional products merely fill without treating, offering no biological action to regenerate the skin.
About us
Combining scientific innovation with a business vision
The KYLYS project began in 2017, born from the discovery of a revolutionary hyaluronic acid-based technology by researchers at the University of Geneva. After several years of R&D and nearly CHF 2 million invested, KYLYS AESTHETICS SA was founded to transform the aesthetic medicine sector.
Our ambition is to move the market towards more natural, effective and scientifically validated solutions, by offering a superior alternative to traditional fillers.
Our roadmap
A clear growth strategy
From scientific discovery to global expansion, our key milestones demonstrate our momentum and market potential.
2025 - 2027
2028+
Our team
Experts in science, finance and aesthetic medicine
A complementary executive team and scientific advisory board, united by a common vision of excellence and responsible innovation.
News
Our latest news
Stay up-to-date with the latest advancements from KYLYS AESTHETICS and our key partnerships.
CHF 1 Million raised to accelerate our development
KYLYS AESTHETICS SA has successfully closed a funding round to move forward with the development and clinical validation of its Class III medical device. This
Medical Aesthetic Injectable Summit
KYLYS AESTHETICS SA is delighted to participate in the inaugural Medical Aesthetic Injectable Summit 2024 (#MAIS2024)! We are honored to be…
New Partnership with FONGIT
We are proud to announce our new partnership with FONGIT. This collaboration aims to establish a strong framework for cooperation, facilitating the exchange of…
Contact us
For any inquiries, press, or partnership opportunities, feel free to use the form or contact us directly.
